(S (NP (NNP Melanoma)) (VP (VBZ is) (NP (NP (DT a) (NN type)) (PP (IN of) (NP (NP (NN skin) (NN cancer)) (PP (IN with) (NP (DT the) (ADJP (ADVP (RBS most) (RB rapidly)) (VBG increasing)) (NN incidence))))))) (. .))
(S (NP (NP (RB Early) (NN detection)) (PP (IN of) (NP (NP (NN melanoma)) (VP (VBG using) (NP (NN dermoscopy) (NNS images)) (ADVP (RB significantly)))))) (VP (VBZ increases) (NP (NP (NNS patients) (POS ')) (NN survival) (NN rate))) (. .))
(S (ADVP (RB However)) (, ,) (S (ADVP (RB accurately)) (VP (VBG classifying) (NP (NN skin) (NNS lesions)) (PP (PP (IN by) (NP (NN eye))) (, ,) (RB especially) (PP (IN in) (NP (NP (DT the) (JJ early) (NN stage)) (PP (IN of) (NP (NN melanoma)))))))) (, ,) (VP (VBZ is) (ADJP (RB extremely) (JJ challenging) (PP (IN for) (NP (DT the) (NNS dermatologists))))) (. .))
(S (ADVP (RB Hence)) (, ,) (NP (NP (DT the) (NN discovery)) (PP (IN of) (NP (JJ reliable) (NNS biomarkers)))) (VP (MD will) (VP (VB be) (ADJP (JJ meaningful) (PP (IN for) (NP (NN melanoma) (NN diagnosis)))))) (. .))
(S (NP (NP (JJ Recent) (NNS years)) (, ,) (NP (NP (DT the) (NN value)) (PP (IN of) (NP (NP (JJ deep) (NN learning)) (SBAR (S (VP (VBD empowered) (ADJP (ADJP (NN computer) (HYPH -) (VBN assisted)) (FRAG (VP (VB diagnose))))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (PP (IN in) (NP (ADJP (NML (JJ biomedical) (NN imaging)) (VBN based)) (NN decision) (NN making)))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (JJ much) (NN research)) (VP (VBZ focuses) (PP (IN on) (S (VP (VP (VBG improving) (NP (NN disease) (NN detection) (NN accuracy))) (CONJP (CC but) (RB not)) (VP (VBG exploring) (NP (NP (DT the) (NN evidence)) (PP (IN of) (NP (NN pathology))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (DT a) (NN method)) (S (VP (TO to) (VP (VB interpret) (NP (DT the) (JJ deep) (NML (NN learning) (NN classification)) (NNS findings)))))) (. .))
(S (ADVP (RB Firstly)) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (DT an) (JJ accurate) (NML (JJ neural) (NN network)) (NN architecture)) (S (VP (TO to) (VP (VB classify) (NP (NN skin) (NNS lesions)))))) (. .))
(S (ADVP (RB Secondly)) (, ,) (NP (PRP we)) (VP (VBP utilize) (NP (NP (DT a) (NN prediction) (NN difference) (NN analysis) (NN method)) (SBAR (WHNP (WDT that)) (S (VP (VBZ examines) (NP (NP (DT each) (NN patch)) (PP (IN on) (NP (DT the) (NN image)))) (PP (IN through) (S (VP (VBN patch-wised) (NP (NN corrupting)) (S (VP (TO to) (VP (VB detect) (NP (DT the) (NNS biomarkers))))))))))))) (. .))
(S (ADVP (RB Lastly)) (, ,) (NP (PRP we)) (VP (VBP validate) (SBAR (IN that) (S (NP (PRP$ our) (NN biomarker) (NNS findings)) (VP (VBP are) (VP (VBG corresponding) (PP (IN to) (NP (NP (DT the) (NNS patterns)) (PP (IN in) (NP (DT the) (NN literature)))))))))) (. .))
(S (NP (DT The) (NNS findings)) (VP (MD can) (VP (VB be) (ADJP (JJ significant) (CC and) (JJ useful) (S (VP (TO to) (VP (VB guide) (NP (JJ clinical) (NN diagnosis)))))))) (. .))
